In the News

501 News Items found
Memorial Sloan Kettering medical oncologist Dean Bajorin
Q&A
People with bladder cancer may soon have a new treatment option following surgery.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
Jung Hun Oh
Lung cancer co-opts genes that normally help a fetus develop and evade the mother’s immune system — leading to poorer outcomes in female patients, an MSK research team has found.
Internist Francesca Gany is seen leaning on a taxicab and smiling. She leads the MSK Immigrant Health & Cancer Disparities Service, which this year marks its tenth anniversary
The MSK Immigrant Health & Cancer Disparities service improves people’s lives in communities that too often get overlooked and suffer disproportionately from cancer, including lack of access to care.
Fiber-rich foods including nuts, seeds, lentils, and whole-grain pasta arranged against white backdrop
Experts in nutrition and cancer at MSK explain what a high-fiber diet looks like — and why it may lower your risk of developing certain cancers.
2018
Roundup
Take a look back at some of the year’s biggest news in cancer research.
A mother being treated for cancer breast-feeds her baby.
Ask the Expert
Here’s what to know about breast-feeding during chemotherapy and other treatments for cancer.
Memorial Sloan Kettering surgeon Andrea Barrio
Ask the Expert
Learn about the breast cancer type called ductal carcinoma in situ (DCIS) and how doctors decide on the best treatment for each person.
Illustration of a magnifying glass and DNA sequences
Finding
MSK investigators report a new tool that may help them determine the origin of some metastatic tumors, potentially leading to better targeted treatments.